Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case f…
The bill prohibits life, disability, and qualified long-term care insurers from denying coverage, canceling coverage, or varying premiums or terms solely on the basis that a person is a living organ donor, unless there are actual, unique, and material actuarial risks tied to donor status. State insurance regulators are authorized to enforce that prohibition under state law.
Strength of federal enforcement vs. reliance on state regulators: liberals want stronger federal oversight; conservatives emphasize state primacy.
Relative to its intended legislative type, this bill sets a clear substantive prohibition against insurer actions based on living organ donor status and assigns HHS responsibility for updating public education materials, but it leaves significant implementation, enforcement, and definitional details unspecified.
The bill prohibits life, disability, and qualified long-term care insurers from denying coverage, canceling coverage, or varying premiums or terms solely on the basis that a person is a living organ donor, unless there are actual, unique, and material actuarial risks tied to donor status.
State insurance regulators are authorized to enforce that prohibition under state law.
The Secretary of Health and Human Services must, within six months of enactment, review and update public educational materials about the benefits and risks of living organ donation and the law’s effects on access to insurance.
On content alone, the bill is a narrowly targeted, low-cost, administrative protection that should attract bipartisan sympathy and limited organized opposition. Its clear definitions, modest administrative requirement for HHS, and allowance for actuarial justification reduce contentiousness. Remaining risks include insurer or state regulator objections, coordination issues between federal standard and state enforcement, and potential delays in the Senate or at the committee stage.
Relative to its intended legislative type, this bill sets a clear substantive prohibition against insurer actions based on living organ donor status and assigns HHS responsibility for updating public education materials, but it leaves significant implementation, enforcement, and definitional details unspecified.
Strength of federal enforcement vs. reliance on state regulators: liberals want stronger federal oversight; conservatives emphasize state primacy.
These are examples from the analysis, not a ranked list of the most-affected groups.
Strength of federal enforcement vs. reliance on state regulators: liberals want stronger federal oversight; conservatives emphasize state primacy.
This persona would generally view the bill positively as a targeted civil-rights-style protection for people who donate organs while alive, removing a documented barrier to donation.
They would see the HHS education requirement as helpful to reduce misinformation and encourage donation, while noting the enforcement depends on state regulators.
They might want stronger federal enforcement language or monitoring to ensure insurers do not use donor status indirectly as a proxy for risk.
A centrist would likely see this as a narrowly tailored, low-cost measure encouraging public health (organ donation) while preserving insurers’ ability to rely on legitimate actuarial evidence.
They would approve of the HHS education update but note the bill mostly relies on existing state insurance enforcement.
They would weigh potential small actuarial impacts against the public benefit of more living donors and expect limited controversy.
A mainstream conservative would generally favor protections for living organ donors as a social good but may be wary of federal intrusion into an area traditionally regulated by states and of restrictions on insurers’ actuarial judgment.
They would appreciate the bill’s narrow scope and state enforcement role, but might press for clearer preservation of insurers’ ability to set rates where actuarial evidence supports it.
Overall, many conservatives would find the bill acceptable though some could object on principle to federal standard-setting in insurance.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a narrowly targeted, low-cost, administrative protection that should attract bipartisan sympathy and limited organized opposition. Its clear definitions, modest administrative requirement for HHS, and allowance for actuarial justification reduce contentiousness. Remaining risks include insurer or state regulator objections, coordination issues between federal standard and state enforcement, and potential delays in the Senate or at the committee stage.
The bill has not accumulated any surfaced votes yet.
Strength of federal enforcement vs. reliance on state regulators: liberals want stronger federal oversight; conservatives emphasize state p…
On content alone, the bill is a narrowly targeted, low-cost, administrative protection that should attract bipartisan sympathy and limited…
Relative to its intended legislative type, this bill sets a clear substantive prohibition against insurer actions based on living organ donor status and assigns HHS responsibility for updating public education materials…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.